Avalanche's AVAX has erased the gain it made after Ava Labs tied the network to an NYSE-affiliated tokenized stock platform. The chart still favors sellers, and the deal leaves the token without a stated role.
AVAX tumbled about 10.9% in a single day on Nov 14, landing near $7.49 and wiping out the entire gain from the NYSE news. For a few days, the token had fallen less than bitcoin, ether and solana.
The NYSE deal that briefly set AVAX apart
On Nov 9, Ava Labs said Avalanche will act as the ledger for the clearing firm behind a new tokenized stock platform affiliated with the New York Stock Exchange. AVAX jumped about 8.9% that session to near $9.
Over the following week, the token lost about 9.1%, while Bitcoin fell 13%, Ether dropped 17.6% and Solana slid 18.9%.
The deal has limits, however. The platform still needs regulatory approval, and neither the clearing firm nor a launch date has been named. Ava Labs did not specify AVAX for settlement, fees or staking.
AVAX traded near $7.23 at last check, up about 2% over the past day.
Price sits beneath both long averages
Both long averages now sit above the price. The 50-day moving average stands near $8.80, and the 200-day average is close to $8.98. Buyers would need to clear both to turn the trend up.
Over the month, the decline looks steadier. AVAX has lost about 28% over 30 days, with each rebound fading below the last.
Momentum points the same way. RSI reads about 33, weak but not yet below 30, the line that marks oversold conditions. The MACD also remains under its signal line.
Where the floor and ceiling sit
A daily close back above resistance near $7.77 would show buyers still trust the NYSE deal. Above that, the next resistance stands near $8.26.
Support forms a tight cluster between roughly $6.22 and $6.24, about 14% below current trading. Below it, the next marker is the one-year low near $5.89, set on June 19.
Wider demand is also weak: spot bitcoin ETFs saw about $1.28 billion in outflows in early November.
Source: Crypto Daily™
Trading involves risk.
Risk Disclaimer
